BSE filing, NSE: REFEX. Summary written from the filing by ALFA Finder's alert engine.
Refex Industries Ltd: key numbers
- Share price
- ₹231.28
- Market cap
- ₹3,174 Cr
- Revenue (annual)
- ₹2,277 Cr
- Net profit (annual)
- ₹203.3 Cr
- P/E (TTM)
- 12.3×Sector 50.9×
- Promoter holding
- 56.56%-0.01% QoQ
- FII holding
- 0.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Refex Industries Ltd
All →Refex Industries Other Announcement
Refex Industries' quarterly shareholding pattern as of 30 September 2026 shows promoter holdings of about 56.6% and total public shareholding details. The filing reports no promoter transaction or change in control.
Refex Industries Share Pledge
Refex Holding pledged shares to multiple entities, raising encumbered stake to 29.06% of capital. Pledged shares now total 51.37% of promoter holding.
Refex Industries Earnings Call Transcript: Key Takeaways
Refex reported strong revenue growth led by Ash/Coal handling, despite seasonal monsoon headwinds, while pivoting into a capital-light RMC business model.
- Call
- Guides 25% growth
Refex Industries Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue ₹559.5 Cr (+36.1%), PAT ₹59.5 Cr (+13.1%); H1 revenue ₹1,178.8 Cr (+54.7%), PAT ₹133.2 Cr (+55.4%). Order book ₹1,721 Cr; RMC and wind ramping.
Refex Industries Results Update
Refex Industries reported Q2FY27 revenue of ₹560 cr (up 36.1% YoY) and PAT of ₹60 cr (up 13.1% YoY). H1FY27 PAT rose 55.4% to ₹133.2 cr.
Refex Industries Q2 FY27 Results: Net Profit ₹50.7 Cr, Up 40.1% YoY
Refex Industries Ltd reported revenue from operations of ₹761.3 Cr (+83.6% YoY) and net profit of ₹50.7 Cr (+40.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹50.7 Cr · +40.1% YoY
Other employee stock options announcements
All →Sai Life Science Employee Stock Options
Sai Life Sciences allotted 108,005 ESOP equity shares, taking paid-up capital to Rs.21.26 Crore. No stated consideration means no event value.
Billionbrains Garage Ventures Employee Stock Options
Billionbrains Garage Ventures granted 21,63,086 stock options to eligible employees under its 2024 ESOP scheme. Each option carries an exercise price of Rs. 2 per share.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Zensar Technologies Employee Stock Options
Zensar Technologies allotted 31,440 equity shares to employees on exercise of ESOPs. Paid-up share capital rose to ₹45.55 crore across 22.78 crore shares.
IIFL Finance Employee Stock Options
IIFL Finance allotted 1,97,523 equity shares to eligible employees on exercise of ESOPs, approved by the NRC on 5 November 2026. No cash consideration per share is stated in the filing.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.